Neural Regeneration Research ›› 2024, Vol. 19 ›› Issue (7): 1454-1462.doi: 10.4103/1673-5374.385841

Previous Articles     Next Articles

Cognitive impairment in cerebral small vessel disease induced by hypertension

Weipeng Wei1, 2, Denglei Ma1, 2, Lin Li1, 2, Lan Zhang1, 2, *   

  1. 1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China; 2Beijing Geriatric Medical Research Center; Beijing Engineering Research Center for Nervous System Drugs; National Center for Neurological Disorders; National Clinical Research Center for Geriatric Diseases, Beijing, China
  • Online:2024-07-15 Published:2023-11-28
  • Contact: Lan Zhang, PhD, xwzhanglan@126.com.
  • Supported by:
    This work was supported by the National Natural Science Foundation of China, Nos. 82274611 (to LZ), 82104419 (to DM); Capital Science and Technology Leading Talent Training Project, No. Z191100006119017 (to LZ); Beijing Hospitals Authority Ascent Plan, No. DFL20190803 (to LZ); Cultivation Fund of Hospital Management Center in Beijing, No. PZ2022006 (to DM); R&D Program of Beijing Municipal Education Commission, No. KM202210025017 (to DM); and Beijing Gold-Bridge Project, No. ZZ20145 (to DM).

Abstract: Hypertension is a primary risk factor for the progression of cognitive impairment caused by cerebral small vessel disease, the most common cerebrovascular disease. However, the causal relationship between hypertension and cerebral small vessel disease remains unclear. Hypertension has substantial negative impacts on brain health and is recognized as a risk factor for cerebrovascular disease. Chronic hypertension and lifestyle factors are associated with risks for stroke and dementia, and cerebral small vessel disease can cause dementia and stroke. Hypertension is the main driver of cerebral small vessel disease, which changes the structure and function of cerebral vessels via various mechanisms and leads to lacunar infarction, leukoaraiosis, white matter lesions, and intracerebral hemorrhage, ultimately resulting in cognitive decline and demonstrating that the brain is the target organ of hypertension. This review updates our understanding of the pathogenesis of hypertension-induced cerebral small vessel disease and the resulting changes in brain structure and function and declines in cognitive ability. We also discuss drugs to treat cerebral small vessel disease and cognitive impairment.

Key words: blood-brain barrier, cerebral small vessel disease, cognitive impairment, dementia, endothelial dysfunction, enlarged perivascular space, hypertension, lacunar infarction, neuroinflammation, treatment, white matter high signal intensity